Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Metrics to compare | WANB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWANBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.4x | 23.8x | −0.6x | |
PEG Ratio | −3.34 | 0.17 | 0.00 | |
Price/Book | 6.7x | 2.8x | 2.6x | |
Price / LTM Sales | 1.1x | 3.7x | 3.4x | |
Upside (Analyst Target) | - | 41.1% | 44.9% | |
Fair Value Upside | Unlock | 1.1% | 6.7% | Unlock |